EPA, linolenic, linoleic acids inhibit ACE2 SARS-CoV-2 binding, cellular entry

Original title: "Polyunsaturated ω-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry" (March 04, 2021).

.

A new drug target in the fight against COVID-19, University of Bristol (September 21, 2020):

https://www.youtube.com/watch?v=EMaKFcpV5wg

Discovery of a druggable pocket in the SARS-CoV-2 spike protein:

https://news.ycombinator.com/item?id=24567458

Expert reaction to study on ‘druggable pocket’ in structure of SARS-CoV-2 virus spike:

https://www.sciencemediacentre.org/expert-reaction-to-study-...

  The linoleic acid-binding pocket in SARS-COV-2 will make an attractive target for possible designer drugs..

.

Oils Rich in Linoleic Acid (Safflower, Grapeseed 73%, Poppyseed, Sunflower, Hemp, Corn, Wheatgerm, Cottonseed, Soybean, Walnut, Sesame 45%) :

https://www.news-medical.net/health/Oils-Rich-in-Linoleic-Ac...

??

( BTW some comment from discussion about "Ultraprocessed Foods – A New Theory of Obesity":

https://news.ycombinator.com/item?id=21073302 )

There was another discussion in November about hrsACE2 which as well inhibits binding:

https://news.ycombinator.com/item?id=25008048

https://www.youtube.com/watch?v=EMaKFcpV5wg

  APN001 is a hrsACE2 designed by Apeiron Biologics to imitate the human enzyme ACE2. 
  hrsACE2 at tissue sites can effectively compete with the endogenous ACE2 and limits SARS-CoV-2 entrance into the host cells